These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Folic Acid-Targeted Etoposide Cubosomes for Theranostic Application of Cancer Cell Imaging and Therapy. Tian Y; Li JC; Zhu JX; Zhu N; Zhang HM; Liang L; Sun L Med Sci Monit; 2017 May; 23():2426-2435. PubMed ID: 28529305 [TBL] [Abstract][Full Text] [Related]
5. Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy. Singh S; Sachan K; Verma S; Singh N; Singh PK Curr Pharm Biotechnol; 2024; 25(6):757-771. PubMed ID: 37929730 [TBL] [Abstract][Full Text] [Related]
6. Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy. Shin MC; Zhang J; Ah Min K; Lee K; Moon C; Balthasar JP; Yang VC J Control Release; 2014 Nov; 194():197-210. PubMed ID: 25204286 [TBL] [Abstract][Full Text] [Related]
7. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment. Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868 [TBL] [Abstract][Full Text] [Related]
8. Cubosomes for topical delivery of the antimicrobial peptide LL-37. Boge L; Hallstensson K; Ringstad L; Johansson J; Andersson T; Davoudi M; Larsson PT; Mahlapuu M; Håkansson J; Andersson M Eur J Pharm Biopharm; 2019 Jan; 134():60-67. PubMed ID: 30445164 [TBL] [Abstract][Full Text] [Related]
9. Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems. Madheswaran T; Kandasamy M; Bose RJ; Karuppagounder V Drug Discov Today; 2019 Jul; 24(7):1405-1412. PubMed ID: 31102731 [TBL] [Abstract][Full Text] [Related]
10. Clickable Cubosomes for Antibody-Free Drug Targeting and Imaging Applications. Alcaraz N; Liu Q; Hanssen E; Johnston A; Boyd BJ Bioconjug Chem; 2018 Jan; 29(1):149-157. PubMed ID: 29182866 [TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells. Pereira I; Sousa F; Kennedy P; Sarmento B Int J Pharm; 2018 Oct; 549(1-2):397-403. PubMed ID: 30110619 [TBL] [Abstract][Full Text] [Related]
12. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake. Luo Q; Lin T; Zhang CY; Zhu T; Wang L; Ji Z; Jia B; Ge T; Peng D; Chen W Int J Pharm; 2015 Sep; 493(1-2):30-9. PubMed ID: 26209071 [TBL] [Abstract][Full Text] [Related]
13. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes. Saber MM; Al-Mahallawi AM; Nassar NN; Stork B; Shouman SA BMC Cancer; 2018 Aug; 18(1):822. PubMed ID: 30111296 [TBL] [Abstract][Full Text] [Related]
14. Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer. Vassileva V; Rajkumar V; Mazzantini M; Robson M; Badar A; Sharma S; Årstad E; Hochhauser D; Lythgoe MF; Kinghorn J; Boxer GM; Pedley RB J Nucl Med; 2015 Aug; 56(8):1239-45. PubMed ID: 26045312 [TBL] [Abstract][Full Text] [Related]
15. Cubosomes as an emerging platform for drug delivery: a review of the state of the art. Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858 [TBL] [Abstract][Full Text] [Related]